logo
Plus   Neg
Share
Email

Sanofi Appoints Novartis Executive Paul Hudson As CEO

French drug giant Sanofi SA (SNYNF,SNY) said Friday that it appointed Paul Hudson, 51 years, as its Chief Executive Officer, to succeed Olivier Brandicourt who has decided to retire.

Paul Hudson, who most recently was Chief Executive Officer of Novartis Pharmaceuticals and Member of the Executive Committee of Novartis, will replace Brandicourt on September 1, 2019.

Paul Hudson spent his 28-years career with major pharmaceutical companies such as Schering Plough, Astra Zeneca and Novartis. He will move to Paris.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Google announced a new $600 million investment for the expansion of Mayes County data center. The tech giant had started the data center in 2007 and expanded three times already. The new investment will add 100 jobs to Pryor community, Google CEO Sundar Pichai said during the announcement. In... King Arthur Flour, Inc. voluntarily recalled certain lots of 5 lb. Unbleached All-Purpose Flour due to the potential presence of Escherichia coli bacteria (E. coli), The U.S. Food and Drug Administration (FDA) stated. The company announced it is recalling 14,218 cases of the potentially affected lots that were distributed through retailers and distributors nationwide. Burger King has launched a new Upside Down Whopper in celebration of the third season of Netflix series "Stranger Things." The hamburger chain, in partnership with Netflix, announced it will start selling an Upside Down Whopper sandwich, which is just a regular Whopper served upside down, from June...
Follow RTT